SOPHiA GENETICS

SOPHiA GENETICS offers SOPHiA DDM™, a cloud-based AI platform that analyzes complex health data, mainly genomic data, to support decisions in oncology and inherited disorders. The website also lists radiomics, multimodal analysis, Alamut™ Visual Plus, OncoPortal™ and professional enablement services as parts of its offering.

The website names providers (oncologists, radiologists, pathologists, geneticists, lab technicians, bioinformaticians), biopharma companies and patients as its audiences. Some SOPHiA DDM™ Dx solutions are listed as CE-IVD products for in vitro diagnostic use in specified regions, while other products are labeled for research use only. The website does not describe its pricing or revenue model.

The company was founded in 2011 and states that it connects more than 1,000 healthcare institutions in over 75 countries, with 2.6M+ genomic profiles analyzed and 400+ employees across 3 global offices. Current job listings are in Boston (US), Rolle (Switzerland) and several remote roles in Europe, the US and Asia-Pacific, mainly in clinical sales, software engineering, finance and regulatory and clinical affairs.

Product: SOPHiA DDM™, a cloud-based AI platform for genomic, radiomic and multimodal data analysis in oncology and rare inherited disorders.